Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Venkatesan Jay Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2022 4 Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Exercised 20,063 options to buy @ $0.45, valued at $9k
05/27/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2022 4 Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Granted 10,000 options to buy @ $0
12/29/2021 4 Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Bought 66,907 shares @ $2.5486, valued at $170.5k
Bought 210,337 shares @ $2.6617, valued at $559.9k
12/22/2021 4 Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Bought 3,527 shares @ $2.5449, valued at $9k
12/20/2021 4 Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Bought 27,883 shares @ $2.5461, valued at $71k
Bought 13,742 shares @ $2.5439, valued at $35k
12/17/2021 4 Venkatesan Jay (See Remarks) has filed a Form 4 on Angion Biomedica Corp.
Txns: Paid exercise price by delivering 41,091 shares @ $13.78, valued at $566.2k
Bought 77,604 shares @ $2.4091, valued at $187k
09/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2020 4 Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Disposed of 993,801 shares @ $0
Acquired 181,024 shares @ $0
07/08/2020 4 Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns: Exercised 9,310 options to buy @ $0.65, valued at $6.1k
Exercised 12,930 options to buy @ $1.03, valued at $13.3k
06/08/2020 4 Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns: Granted 21,693 options to buy @ $2.79, valued at $60.5k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/06/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2019 4 Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns: Granted 21,693 options to buy @ $2.78, valued at $60.3k
01/22/2019 4 Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Bought 190,875 shares @ $5.37, valued at $1M
Bought 74,441 warrants @ $12.74, valued at $948.4k
01/04/2019 4 Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Granted 7,650 options to buy @ $0
06/21/2018 4 Venkatesan Jay (Director) has filed a Form 4 on EXICURE, INC.
Txns: Granted 21,693 options to buy @ $5.82, valued at $126.3k
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2017 4 Venkatesan Jay (Director) has filed a Form 4 on Max-1 Acquisition Corp
Txns: Acquired 190,957 shares @ $0
Acquired 90,192 shares @ $0
Granted 52,234 shares @ $0
Bought 66,666 shares @ $3, valued at $200k
Granted 9,309 options to buy @ $0
Granted 12,929 options to buy @ $0
Granted 24,824 options to buy @ $0
09/28/2017 3 Venkatesan Jay (Director) has filed a Form 3 on Max-1 Acquisition Corp
07/26/2017 4 Venkatesan Jay (President) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Acquired 18,633 shares @ $0
Granted 21,739 shares @ $0
Acquired 3,803,906 shares @ $0
Granted 90,063 options to buy @ $0
07/26/2017 3 Venkatesan Jay (President) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC.
06/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/16/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
12/16/2014 4 Venkatesan Jay (EVP and General Manager) has filed a Form 4 on Oncothyreon Inc.
Txns: Granted 100,000 options to buy @ $1.76, valued at $176k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy